{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:24:47Z","timestamp":1761765887716,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.acvd.2014.10.006","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T21:07:05Z","timestamp":1425589625000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and echographic characteristics of patients exposed to fenfluramin or its derivatives: Results of a prospective, single-centre, observational study"],"prefix":"10.1016","volume":"108","author":[{"given":"David","family":"Cambon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2014.10.006_bib0110","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.1371\/journal.pone.0010128","article-title":"Benfluorex and unexplained valvular heart disease: a case-control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2014.10.006_bib0115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ejechocard\/jeq027","article-title":"Restrictive organic mitral regurgitation associated with benfluorex therapy","volume":"11","author":"Tribouilloy","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2014.10.006_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ejechocard\/jeq172","article-title":"Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry","volume":"12","author":"Le Ven","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2014.10.006_bib0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.acvd.2014.10.006_bib0130","doi-asserted-by":"crossref","first-page":"A76","DOI":"10.1016\/S1262-3636(10)70309-8","article-title":"Comparaison \u00e0 1 an de benfluorex et pioglitazone dans le diab\u00e8te de type 2\u00a0: \u00e9tude regulate","volume":"36","author":"Moulin","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.acvd.2014.10.006_bib0135","doi-asserted-by":"crossref","first-page":"e38273","DOI":"10.1371\/journal.pone.0038273","article-title":"Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus","volume":"7","author":"Derumeaux","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2014.10.006_bib0140","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","article-title":"Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus","volume":"19","author":"Weill","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.acvd.2014.10.006_bib0145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.lpm.2011.03.001","article-title":"[Number of deaths attributable to benfluorex]","volume":"40","author":"Hill","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.acvd.2014.10.006_bib0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.lpm.2011.09.001","article-title":"[Benfluorex and valvular heart disease]","volume":"40","author":"Tribouilloy","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.acvd.2014.10.006_bib0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.acvd.2014.10.006_bib0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.10.006_bib0165","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2010.03.019","article-title":"Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium","volume":"55","author":"Thanassoulis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.10.006_bib0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.arcmed.2008.12.003","article-title":"Aortic and mitral valve atherosclerosis: predictive factors and associations with coronary atherosclerosis using Gensini score","volume":"40","author":"Anvari","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.acvd.2014.10.006_bib0175","first-page":"126","article-title":"[Fenfluramine as an oral antidiabetic]","volume":"125","author":"Hepp","year":"1983","journal-title":"MMW Munch Med Wochenschr"},{"key":"10.1016\/j.acvd.2014.10.006_bib0180","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/archinte.161.11.1429","article-title":"Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial","volume":"161","author":"Davidoff","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2014.10.006_bib0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.10.006_bib0190","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0735-1097(99)00445-3","article-title":"Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment","volume":"34","author":"Weissman","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.10.006_bib0195","first-page":"688","article-title":"Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease","volume":"12","author":"Boudes","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.acvd.2014.10.006_bib0200","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1378\/chest.105.2_Supplement.37S","article-title":"The International Primary Pulmonary Hypertension Study, (IPPHS)","volume":"105","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2014.10.006_bib0205","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0735-1097(99)00321-6","article-title":"Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30months","volume":"34","author":"Burger","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.10.006_bib0210","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1093\/eurheartj\/eht266","article-title":"Frequency of drug-induced valvular heart disease in patients previously exposed to benfluorex: a multicentre prospective study","volume":"34","author":"Tribouilloy","year":"2013","journal-title":"Eur Heart J"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521361500011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521361500011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:42:11Z","timestamp":1761745331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187521361500011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S187521361500011X"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2014.10.006","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and echographic characteristics of patients exposed to fenfluramin or its derivatives: Results of a prospective, single-centre, observational study","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}